Relay Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $92.0M | $844.0M | $143.7M |
| FY2024 | $93.5M | $871.3M | $124.3M |
| FY2025 | $54.3M | $621.3M | $84.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $92.0M | $844.0M | $143.7M |
| FY2024 | $93.5M | $871.3M | $124.3M |
| FY2025 | $54.3M | $621.3M | $84.0M |